Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-20-004160
Filing Date
2020-02-18
Accepted
2020-02-18 17:16:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b3021520b_citiuspharma.htm 424B3 33020
2 GRAPHIC img_001.jpg GRAPHIC 29963
  Complete submission text file 0001213900-20-004160.txt   75591
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-230919 | Film No.: 20626394
SIC: 2834 Pharmaceutical Preparations